The Role of Antiangiogenic Agents in the Treatment of Head and Neck Cancer

Publisher： Karger

E-ISSN： 1423-0232|83|2|108-116

ISSN： 0030-2414

Source： Oncology, Vol.83, Iss.2, 2012-07, pp. : 108-116

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Role of Radiotherapy in the Definitive and Postoperative Treatment of Advanced Head and Neck Cancer

By  

Oncology Research and Treatment, Vol. 40, Iss. 6, 2017-05 ,pp. : 347-352

Karger

Access to resources Recommend Favorite

Ifosfamide in the Treatment of Head and Neck Cancer

By  

Oncology, Vol. 65, Iss. 2, 2003-11 ,pp. : 37-43

Karger

Access to resources Recommend Favorite

Is There a Role for Chemosensitivity Tests in Head and Neck Cancer?

By  

Oncology Research and Treatment, Vol. 27, Iss. 3, 2004-07 ,pp. : 310-315

Karger

Access to resources Recommend Favorite

Role of autophagy in head and neck cancer and therapeutic resistance

By  

ORAL DISEASES, Vol. 21, Iss. 3, 2015-04 ,pp. : 283-291

John Wiley & Sons Inc

Access to resources Recommend Favorite

Quantifying fibrosis in head and neck cancer treatment: An overview

By  

HEAD & NECK: JOURNAL FOR THE SCIENCES & SPECIALTIES OF THE HEAD AND NECK, Vol. 37, Iss. 8, 2015-08 ,pp. : 1225-1231

John Wiley & Sons Inc

Access to resources Recommend Favorite